News and Comments

AGEN: IRRATIONAL REACTION AGAINST EXPECTED NEWS

  Thursday, March 20, 2014
 More...

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...

JAKAFI DEVELOPED BY INCYTE MET THE PRIMARY ENDPOINTS FOR POLYCYTHEMIA VERA

  Friday, March 07, 2014

Incyte (INCY) announced results from pivotal Phase 3 trial of Jakafi (ruxolitinib) in polycythemia vera patients who are resistant to or intolerant of hydroxyurea. The results met the primary endpoints; achieving phlebotomy independence and reducing spleen size by 35 percent or more compared to best available therapy.  More...


Recent Postings


Archive


Tags

Bristol-Myers Squibb (BMY) ZALTRAP™ Intrexon (XON) LEXICON (LXRX) Biocryst (BCRX) Bellicum (BLCM) Alnylam (ALNY) VANDA (VNDA) Seattle Genetics (SGEN) ARGOS (ARGS) Anadys (ANDS) Endometrial Cancer Roche (RHHBY) JUNO (JUNO) Auspex (ASPX) Illumina (ILMN) AERIE PHARMACEUTICALS Alder Biopharmaceuticals (ALDR) Zerenex Regeneron (REGN) Human Longevity (HLI) BIOMARIN (BMRN) TOKAI (TKAOI) IDERA (IDRA) ARCA (ABIO) JOUNCE THERAPEUTICS (JNCE) NEUROCRINE (NBIX) KERYX (KERX) Sanofi (SNY) PORTOLA (PTLA) Agenus (AGEN Herceptin Biogen Idec (BIIB) NOVOCURE (NVCR) Advaxis (ADXS) NANTKWEST (NK) REGULUS (RGLS) OSI (OSIP) SERES THERAPEUTICS (MCRB) Array Pharmaceuticals (ARRY) Tysabri Human Genome Sciences (HGSI) CRISPR Therapeutics (CRSP) Vertex (VRTX) PTC Therapeutics (PTCT) ACADIA (ACAD) Jazz Pharmaceuticals (JAZZ) Rapamune Intercept (ICPT) Prosensa (RNA) Ocular Therapeutix (OCUL) Vitae Pharmaceuticals (VTAE) Galena (GALE) Global Cell Therapeutics (GBT) Benlysta (belimumab) Roche (ROCHE) Exelixis (EXEL) GUARDIAN HEALTH Incyte (INCY) MODERNA CEMPRA (CEMP) Velcade (bortezomib) ISIS (ISIS) Xoma (XOMA) Ridaforolimus Sarepta (SRPT) Gilead (GILD) Abbott Laboratories (ABT) Anacor (ANAC) Sequenom (SQNM) Idenix (IDIX) Cytokinetics (CYTK) Trastuzumab-DM1 GlaxoSmithKline (GSK) Telaprevir HALOZYME (HALO) Adaptimmune (ADAP) Prolor Biotech (PBTH) Ariad (ARIA) Editas (EDIT) Agenus (AGEN) Mirati Therapeutics (MRTX) Intermune (ITMN) Theravance Bio Pharma (TBPH) galapagos (GLPG) ImmunoGen (IMGN) Elan (ELN) INNOVIVA (INVA) KITE (KITE) NEKTAR (NKTR)) ADVENTRIX (ANX) CompuGen (CGEN) Revlimid (lenolidamide) Sanofi (SNA) Dendreon (DNDN) OncoCyte (OCX) Dynavax (DVAX) Sangamo (SGMO) Spike Therapeutics (ONCE) RenenxBio (RGNX) Genentech Inovio (INO) Aimmune Therapeutics (AIMT) SYNTA (SNTA) Amgen (AMGN) AstraZeneca (AZN) Valeant Pharmaceuticals International (VRX) SUNESIS PHARMACEUTICALS (SNSS) Theravance (THRX) ABBVIE (ABBV) Multiple Myeloma Onyx (ONXX) Micromet (MITI) C4 Therapeutics AGOS (ARGS) Pluristem (PSTI) Ionis (IONS) Ziofpharm (ZIOP) Merck (MRK) Sanofi-Aventis (SAN)